definiens: means, with respect to [COMPANY] ’ obligations under this Agreement to Develop orCommercialize a Compound or Product, the carrying out of such obligations or tasks with a level of effort andresources consistent with the commercially reasonable practices devoted by [COMPANY] for the research, development, manufacture or commercialization of a pharmaceutical product owned by it ( or to which it has exclusive rights ) thatBMS is actively Developing or Commercializing at a similar stage of development or commercialization, and of similarmarket potential, and profit potential, based on conditions then prevailing . Such efforts may take into account, withoutlimitation, issues of safety and efficacy, regulatory authority - approved labeling, product profile, the competitiveness ofalternative products in the marketplace, pricing / reimbursement for the product in a country relative to other markets, the likely timing of the product ’s entry into the market, the patent and other proprietary position, the likelihood ofregulatory approval and other relevant scientific, technical and commercial factors, provided that Diligent Efforts withrespect to a Product requires that [COMPANY] : ( a ) set, and seek to achieve, specific objectives for carrying out itsDevelopment and Commercialization efforts, and ( b ) make and implement decisions and allocate appropriateresources for achieving such objectives . means, with respect to CytomX ’s obligations under thisAgreement, the carrying out of such obligations or tasks with a level of effort and resources consistent with thecommercially reasonable practices normally devoted by a biotechnology company, subject to and in accordance withthe terms and conditions of this Agreement